Results 341 to 350 of about 10,598,225 (397)
Some of the next articles are maybe not open access.

Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.

Journal of the American Medical Association (JAMA), 2022
Importance Pulmonary arterial hypertension (PAH) is a subtype of pulmonary hypertension (PH), characterized by pulmonary arterial remodeling. The prevalence of PAH is approximately 10.6 cases per 1 million adults in the US.
N. Ruopp, B. Cockrill
semanticscholar   +1 more source

Markers of arterial stiffness in peripheral arterial disease.

VASA. Zeitschrift fur Gefasskrankheiten, 2015
Increased arterial stiffness results from reduced elasticity of the arterial wall and is an independent predictor for cardiovascular risk. The gold standard for assessment of arterial stiffness is the carotid-femoral pulse wave velocity. Other parameters
M. Husmann   +3 more
semanticscholar   +1 more source

Peripheral arterial disease

2010
The most common presentations of peripheral arterial disease are intermittent claudication and abdominal aortic aneurysm. In patients under 50 years of age the cause of disease is most likely to be genetic, congenital, immunological, infectious, or traumatic; over 50 years of age the principal risk factor is smoking....
Janet Powell, Alun Davies
openaire   +1 more source

Diabetes and Arterial Disease

Diabetic Medicine, 1991
Macroangiopathy (or atherosclerosis) is a common and chronic complication in diabetic patients. Unlike other diabetic complications, atherosclerosis is not unique to diabetes, confounding analysis of its relationship with the diabetic condition. Evidence of an independent role for diabetes in the development of atherosclerosis remains equivocal.
F. A. Gries, Th. Koschinsky
openaire   +3 more sources

Peripheral arterial disease

The Lancet, 2001
Lower extremity peripheral arterial disease (PAD) most frequently presents with pain during ambulation, which is known as "intermittent claudication". Some relief of symptoms is possible with exercise, pharmacotherapy, and cessation of smoking.
openaire   +2 more sources

Hypercoagulability in Arterial Disease

Angiology, 1989
Isolated human monocytes generate tissue factor when stimulated with endo toxin. Tissue factor generation provides a marker for activation of the monocyte and of the clotting system. Determination of the recalcification time of blood after incubation with endotoxin detects minute changes in coagulability. This clotting assay was utilized to assess the
Charles R. Spillert   +3 more
openaire   +3 more sources

Peripheral arterial disease

Journal of Wound Care, 1996
An update on the epidemiology, pathology and aetiology of vascular disease
K.R. Vowden, P. Vowden
openaire   +3 more sources

Coronary Artery Disease

Anesthesiology, 1970
Coronary artery disease, also known as ischemic heart disease , is the leading killer of men and women worldwide. In 2004, coronary artery disease was responsible for 7.2 million deaths, or 12.2% of all deaths globally and 5.8% of all years of life lost (World Health Organization 2008).
M S Batra   +4 more
openaire   +3 more sources

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.

International Journal of Epidemiology, 1991
Intermittent claudication has been studied in cardiovascular surveys but limited information is available on asymptomatic peripheral arterial disease. The purpose of this paper is to describe the prevalence of both asymptomatic and symptomatic disease ...
F. Fowkes   +5 more
semanticscholar   +1 more source

Peripheral arterial disease

Current Treatment Options in Cardiovascular Medicine, 1999
Risk factors for atherosclerosis should be identified and reduced in all patients who have peripheral arterial disease. Cessation of smoking, strict control of diabetes and hypertension, and aggressive reduction in low-density lipoprotein cholesterol level result in a slowdown of disease progression and a reduction in cardiovascular events.
openaire   +3 more sources

Home - About - Disclaimer - Privacy